1. Home
  2. STVN vs SON Comparison

STVN vs SON Comparison

Compare STVN & SON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • SON
  • Stock Information
  • Founded
  • STVN 1949
  • SON 1899
  • Country
  • STVN Italy
  • SON United States
  • Employees
  • STVN N/A
  • SON N/A
  • Industry
  • STVN Containers/Packaging
  • SON Containers/Packaging
  • Sector
  • STVN Consumer Discretionary
  • SON Consumer Discretionary
  • Exchange
  • STVN Nasdaq
  • SON Nasdaq
  • Market Cap
  • STVN 6.2B
  • SON 5.1B
  • IPO Year
  • STVN 2021
  • SON N/A
  • Fundamental
  • Price
  • STVN $23.67
  • SON $50.49
  • Analyst Decision
  • STVN Buy
  • SON Buy
  • Analyst Count
  • STVN 6
  • SON 5
  • Target Price
  • STVN $27.50
  • SON $59.00
  • AVG Volume (30 Days)
  • STVN 343.4K
  • SON 599.6K
  • Earning Date
  • STVN 11-05-2024
  • SON 02-12-2025
  • Dividend Yield
  • STVN 0.24%
  • SON 4.13%
  • EPS Growth
  • STVN N/A
  • SON N/A
  • EPS
  • STVN 0.48
  • SON 2.91
  • Revenue
  • STVN $1,220,254,294.00
  • SON $6,572,688,000.00
  • Revenue This Year
  • STVN $3.01
  • SON N/A
  • Revenue Next Year
  • STVN $7.16
  • SON $1.53
  • P/E Ratio
  • STVN $49.11
  • SON $17.30
  • Revenue Growth
  • STVN 3.53
  • SON N/A
  • 52 Week Low
  • STVN $16.56
  • SON $48.22
  • 52 Week High
  • STVN $34.73
  • SON $61.73
  • Technical
  • Relative Strength Index (RSI)
  • STVN 77.49
  • SON 41.59
  • Support Level
  • STVN $19.25
  • SON $50.78
  • Resistance Level
  • STVN $24.90
  • SON $52.03
  • Average True Range (ATR)
  • STVN 1.02
  • SON 0.91
  • MACD
  • STVN 0.38
  • SON -0.00
  • Stochastic Oscillator
  • STVN 78.23
  • SON 7.59

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About SON Sonoco Products Company

Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.

Share on Social Networks: